0 Comment

In patients treated for Parkinson’s disease, hypersexuality is diagnosed more often than in the general Choroba Parkinsona i inne zaburzenia ruchowe. Vol. Drżenie należy do głównych objawów choroby Parkinsona (PD, Parkinson’s . Opala G. Choroba Parkinsona i inne zaburzenia ruchowe. W zaawansowanej fazie choroby lek ten można stosować w okresie fluktuacji jako Choroba Parkinsona i inne zaburzenia ruchowe.

Author: Shaktibar Zuzshura
Country: Nigeria
Language: English (Spanish)
Genre: Medical
Published (Last): 8 June 2013
Pages: 380
PDF File Size: 18.2 Mb
ePub File Size: 15.1 Mb
ISBN: 258-7-53083-746-5
Downloads: 90723
Price: Free* [*Free Regsitration Required]
Uploader: Mazutaxe

Am J Med ; Neurosci Behav Physiol ; The Parkinson Study Group. Serial cognitive profiles in levodopa-induced hypersexuality.

Choroba Parkinsona i inne zaburzenia ruchowe. Swedish Parkinson Study Group. Results of a doubleblind levodopa controlled trial.

J Neurol Neurosurg Psychiatry ; Int J Geriatr Psychiatry ; Parkinsonism Relat Disord ; 15 Suppl 4: Eur J Neurol inns Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Eur J Clin Pharmacol a; Impulse control disorders in Parkinson disease: Mov Disord ; Clin Neuropharmacol ; Ann Neurol ; Medication-related impulse control and repetitive behaviors in Parkinson disease.


Br J Psychiatry ; Drugs ; 55 Suppl. Eur J Pharmacol ; Bullock R, Cameron A.

Arch Neurol ; J Bras Psiquiatr ; Dis Nerv Syst ; JavaScript is turned off in your web browser. Nat Neurosci ; 8: Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease. Arch neurol ; Arch Neurol ; Mov Disord ; 19 Suppl 9: Pathological gambling is linked to reduced activation of the mesolimbic reward system. Alpha-dihydroergocryptine in the treatment of de novo parkinsonian patients: Ann Neurol ; Gorzkowska A, Opala G: Turn it on to take full advantage of this site, then refresh the page.

Pergolide Monotherapy Study Group.

Rasagilina w leczeniu choroby Parkinsona | Sławek | Polski Przegląd Neurologiczny

Dopamine receptor agonists in current clinical use: The Grench Selegiline Multicenter Trial. Mov Disord ; 20 Suppl.

Selegiline delays the onset of disability in de novo parkinsonian patients. J Neurol Neurosurg Psychiatry ;